Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community)
MIKAPOCo
1 other identifier
observational
1,000
1 country
1
Brief Summary
Investigators central hypothesis is that it is possible to create libraries of "consistent" Knowledge-Based plan-models derived from large Institutional experiences. These libraries can be used to guide automated RT planning and serve as tools to assist centers for plan quality assurance (QA) and plan prediction. Quantifying Inter-institute variability of RT planning and building libraries of interchangeable and validated multi-Institutional KB plan prediction models is expected to impact on the quality of planning at the national level. The project has the potential of facilitating the introduction of AI approaches in plan optimization, thus reducing intra and inter-Institute planning variability. Improving plan quality is expected to translate into better outcome after RT in terms of local control and, even more, of side effects and Quality of life. Positive impact is also expected in patient selection for advanced techniques, in plan audit and plan optimization in clinical trials, in technology comparison and cost-benefit analyses as well as in the RT educational field.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 28, 2022
CompletedFirst Submitted
Initial submission to the registry
March 12, 2024
CompletedFirst Posted
Study publicly available on registry
March 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2025
CompletedMarch 20, 2024
March 1, 2024
Same day
March 12, 2024
March 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
model interchangeability
interchangeability will be assessed by considering: a) the fraction of patients identified as "anatomy outlier" (in terms of out of the geometric features (GF) boundary of each single model) once the model coming from Institute X is applied to patients of Institute Y (modX-Y) and vice-versa (modY-X); b) the relative differences in DVH predictions between modX-Y and modY-X, including and not including the previously recognized "GF outlier" patients. Based on these results and on their clinical interpretation, sub-groups of KB-models with "high" interchangeability will be tentatively identified and the relationships between GF and interchangeability quantified.
3 years
Interventions
In order to assess inter-Institute variability of DVH prediction of the various models, for the different situations and the different OARs, DVH and dose statistics (min, mean, median, max and SD of the dose received by each OAR) predicted on the patients owning to the different centers by the different models will be compared
Eligibility Criteria
prostate cancer, breast cancer and for selected SBRT situations (spine and prostate, according to RTOG 0631 and 0938 schemes respectively).
You may qualify if:
- real life consecutive (or randomly chosen) plan data of patients treated for prostate cancer during the last 10 years;
- real life consecutive (or randomly chosen) plan data of patients treated for breast cancer during the last 10 years;
- real life consecutive (or randomly chosen) plan data of patients treated for selected SBRT situations (spine and prostate, according to RTOG 0631 and 0938 schemes respectively) during the last 10 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Ospedale San Raffaele
Milan, 20133, Italy
Related Publications (5)
Esposito PG, Castriconi R, Mangili P, Broggi S, Fodor A, Pasetti M, Tudda A, Di Muzio NG, Del Vecchio A, Fiorino C. Knowledge-based automatic plan optimization for left-sided whole breast tomotherapy. Phys Imaging Radiat Oncol. 2022 Jun 23;23:54-59. doi: 10.1016/j.phro.2022.06.009. eCollection 2022 Jul.
PMID: 35814259BACKGROUNDTudda A, Castriconi R, Benecchi G, Cagni E, Cicchetti A, Dusi F, Esposito PG, Guernieri M, Ianiro A, Landoni V, Mazzilli A, Moretti E, Oliviero C, Placidi L, Rambaldi Guidasci G, Rancati T, Scaggion A, Trojani V, Fiorino C. Knowledge-based multi-institution plan prediction of whole breast irradiation with tangential fields. Radiother Oncol. 2022 Oct;175:10-16. doi: 10.1016/j.radonc.2022.07.012. Epub 2022 Jul 19.
PMID: 35868603BACKGROUNDMonticelli D, Castriconi R, Tudda A, Fodor A, Deantoni C, Gisella Di Muzio N, Mangili P, Del Vecchio A, Fiorino C, Broggi S. Knowledge-based plan optimization for prostate SBRT delivered with CyberKnife according to RTOG0938 protocol. Phys Med. 2023 Jun;110:102606. doi: 10.1016/j.ejmp.2023.102606. Epub 2023 May 15.
PMID: 37196603BACKGROUNDCastriconi R, Esposito PG, Tudda A, Mangili P, Broggi S, Fodor A, Deantoni CL, Longobardi B, Pasetti M, Perna L, Del Vecchio A, Di Muzio NG, Fiorino C. Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy. Front Oncol. 2021 Aug 24;11:712423. doi: 10.3389/fonc.2021.712423. eCollection 2021.
PMID: 34504790BACKGROUNDPlacidi L, Griffin P, Castriconi R, Tudda A, Benecchi G, Burns M, Cagni E, Markham C, Landoni V, Moretti E, Oliviero C, Guidasci GR, Meffe G, Rancati T, Scaggion A, McGoldrick K, Panettieri V, Fiorino C. An International Inter-Consortium Validation of Knowledge-Based Plan Prediction Modeling for Whole Breast Radiotherapy Treatment. Cancers (Basel). 2025 Nov 5;17(21):3576. doi: 10.3390/cancers17213576.
PMID: 41228368DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudio Fiorino, Msc
IRCCS Ospedale San Raffaele
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 12, 2024
First Posted
March 19, 2024
Study Start
October 28, 2022
Primary Completion
October 28, 2022
Study Completion
October 28, 2025
Last Updated
March 20, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share